Overview
Conotruncal heart malformations (also known as conotruncal heart defects or outflow tract defects) are a group of congenital heart defects that affect the conotruncal region of the heart — the area where the great arteries (aorta and pulmonary artery) connect to the ventricles. These malformations arise from abnormal development of the cardiac outflow tract during embryogenesis and include conditions such as tetralogy of Fallot, transposition of the great arteries, double outlet right ventricle, truncus arteriosus (persistent truncus arteriosus), and interrupted aortic arch. These defects primarily affect the cardiovascular system and can lead to abnormal blood flow between the heart and lungs or the heart and the rest of the body. Clinical features vary depending on the specific type of malformation but commonly include cyanosis (bluish discoloration of the skin due to low oxygen levels), difficulty breathing, poor feeding, failure to thrive, and heart failure in neonates and infants. Some forms may be detected prenatally through fetal echocardiography. Conotruncal defects are frequently associated with 22q11.2 deletion syndrome (DiGeorge/velocardiofacial syndrome), and genetic evaluation including chromosomal microarray or FISH for 22q11.2 deletion is often recommended. Other genetic causes include mutations in genes such as TBX1, NKX2-5, and GATA4, as well as associations with other chromosomal abnormalities. Treatment is primarily surgical and depends on the specific defect. Many conotruncal malformations require open-heart surgery in the neonatal period or early infancy to restore normal blood flow. Advances in pediatric cardiac surgery have significantly improved outcomes, though long-term follow-up with a cardiologist is essential, as patients may require additional interventions or experience complications such as arrhythmias, valve dysfunction, or ventricular dysfunction over time. Multidisciplinary care involving cardiology, genetics, and developmental specialists is recommended, particularly when associated syndromic features are present.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Conotruncal heart malformations.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Conotruncal heart malformations at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Conotruncal heart malformations.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Conotruncal heart malformations.
Community
No community posts yet. Be the first to share your experience with Conotruncal heart malformations.
Start the conversation →Latest news about Conotruncal heart malformations
No recent news articles for Conotruncal heart malformations.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Conotruncal heart malformations
What is Conotruncal heart malformations?
Conotruncal heart malformations (also known as conotruncal heart defects or outflow tract defects) are a group of congenital heart defects that affect the conotruncal region of the heart — the area where the great arteries (aorta and pulmonary artery) connect to the ventricles. These malformations arise from abnormal development of the cardiac outflow tract during embryogenesis and include conditions such as tetralogy of Fallot, transposition of the great arteries, double outlet right ventricle, truncus arteriosus (persistent truncus arteriosus), and interrupted aortic arch. These defects prim
At what age does Conotruncal heart malformations typically begin?
Typical onset of Conotruncal heart malformations is neonatal. Age of onset can vary across affected individuals.